An exploratory study analyzing the effect of abatacept therapy on serostatus in Japanese real world as well as the relationship between efficacy evaluation with clinical parameters and changes in serostatus
Not Applicable
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000028804
- Lead Sponsor
- agasaki University Graduate School of Biomedical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are judges as inappropriate for enrollment to the study by the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The seroconversion rate of IgM-ACPA at 12 months after treatment
- Secondary Outcome Measures
Name Time Method